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Speculation
The determination of urinary glucaric acid excretion offers the opportunity to ascertain the induction of glucuronidation processes in neonates without the need of exogenous substance load and in those cases in which bilirubin levels are not high enough to allow the easy eval~ation of the action of phenobarbital or similar enzyme inducers.
The application of phenobarbital and of many other substances (15) results in the induction of hepatic microsomal enzymes. The elevated activity of the enzymes of glucuronic acid pathway results in the increased formation of glucuronic acid and in its further transformation in the liver. This could be detected by enhanced elimination of its final products, L-ascorbic acid and D-glucaric acid in the rat, and eventually of L-xylulose in pentosuric patients (6) (Fig. I) .
Enzyme levels can be assayed directly in liver tissue but liver biopsy is rarely justified for this purpose alone. Indirect methods based on the rate of plasma clearance of antipyrine or phenylbutazone are not suitable because of species and genetic variability of drug detoxication (18) . Furthermore, an exogenous bilirubin load in neonates (3) is not appropriate because of further bilirubin increase at this age. The determination of steroid metabolite formation in the liver (e.g., of 6-P-hydroxycortisol) (5) is also difficult and time consuming. The determination of D-glucaric acid in urine is relatively simple; its rate of excretion could be a good index of induction of glucuronic acid pathway enzymes in man. The estimation of urinary glucuronides should represent a direct index of glucuronidating capacity of the liver as glucuronides reflect the changes in the activity of uridine diphosphate glucuronyltransferase after treatment with drugs (e.g., phenobarbital).
SUBJECTS A N D METHODS
Newborn full term healthy boys without blood group incompatibility and without possibility of isoimmunization were investigated. All had negative Coombs test and all were without visible icterus on the first day.
On the Ist, 4th, and 7th days of life, urine was collected for 24 hr for chemical analyses. In the sera from the cord blood and from the venous blood obtained on the 4th and 7th days, bilirubin was estimated by the method of Jendrassik and Grof (8) . Glucaric acid was determined in urine after separation on Dowex 1-X8 column by the colorimetric method of Ishidate et al. (7) . Total urinary glucuronic acid was determined by the method of Fishman and Green (I), and creatinine was measured in urine according to the method of Lieb and Zacherl (I I). The newborn boys were divided into three groups: group I (8 neonates) with an average birth weight of 3,520 g, who were without treatment and served as control subjects, group II (I I neonates) with an average birth weight of 3,480 g, received phenobarbital (20) (Spofa, Czechoslovakia) intramuscularly in an average dose of 10 mg/kg/24 hr divided into 3 doses (total number of doses for each boy was 10, so that the last dose was applied on the 4th day and the first dose was given within 8 hr after birth), and group 111 (10 neonates) with an average birth weight of 3,610 g; the neonates in this group received phenobarbital orally in the form of tablets (21) crushed in tea (22) in the same dosage and according to the same time schedule as group II. The elimination of glucaric and glucuronic acids was also calculated per milligram of creatinine in order to take into account eventual losses of urine during collections.
RESULTS
The results are given in Table 1 . The highest bilirubin levels were reached on the 4th day in all three groups. Slight icterus was seen in group I in three boys, in group II in three boys, and in group I I I in four boys only on the 4th day of lit'e. On the 7th day there was a decrease, which was most marked in group I I , who received phenobarbital intramuscularly, where bilirubin dropped to lower levels when compared with the 7th day level in the control group. The difference on the 7th day between groups I and 11 was slightly bl low the significance level of 0.05 ( t = 2.003; 0.05-< P < 0.1).
Glucuronic acid excretion increased regularly with age in all three groups. Three days of intramuscular or oral phenobarbital application in the previously mentioned dose and in this experimental arrangement did not result in significant increase in urinary glucuronic acid excretion when compared with the control group. Glucaric acid excretion on the 7th day was highest in the neonates who received phenobarbital intramuscularly (group II). The difference between group II and group I (control group) on the 7th day was statistically significant ( t = 2.227, P < 0.05). The 7th day levels of glucaric acid excretion in children who received he no barbital o r a i y in tablets were also higher, but this increase was not significant when compared with the 7th day values in the control group. This trend was less marked when the results of glucaric acid determinations were expressed per milligram of creatinine, since creatinine excretion rate also increased with age (16) and even more markedly in the phenobarbital-treated groups when compared with group I (on the 7th day the excretion in group I was 8.0 In order to show the association between bilirubin decrease in blood and glucaric acid excretion in urine, the blood bilirubin drop from the maximum on the 4th day to the levels on the 7th day (in percentage) was plotted against glucaric acid excretion on the 7th day (micrograms per milligram of creatinine). The values in the s group treated intramuscularly with phenobarbital were used, since here the excretion of glucaric acid was highest. There was a significant correlation (P < 0.05) (Fig. 2) .
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DISCUSSION
The results indicate that with serum bilirubin decrease on phenobarbital treatment urinary glucaric acid excretion increased. This could be proof of increased activity of glucuronic acid pathway resulting especially in enhanced elimination of the final product, glucaric acid. This process was also followed by Maxwell et al. (12) in rats and in patients with Gilbert's syndrome after phenobarbital application. In patients with Gilbert's syndrome ( 5 , 12) there occurred an increase in urinary glucaric acid excretion with simultaneous serum bilirubin decrease, whereas in rats only elevated glucaric acid excretion could be observed. In the group of neonates presented in this paper, similar serum bilirubin decrease with increase in glucaric acid excretion was observed, although with an entirely different method, consisting of a direct measurement after isolation of glucaric acid on ion exchanger. Increased glucaric acid excretion in epileptics under the influence of some anticonvulsive drugs including phenobarbital has been observed by Okada (14) and by Thompson (17) . This was also confirmed by Hunter et al. (5) in patients with Gilbert's syndrome treated with 5,5-diethyl-I-phenylbarbituric acid (23) and in epileptic patients on anticonvulsant treatment.
Glucaric acid determination in urine represents a relatively simple method by which the stimulating action of phenobarbital and eventually of other drugs on the processes connected with glucuronic acid pathway can be assayed. This is especially advantageous in cases where low bilirubin levels do not allow testing of glucuronidation according to the decrease of serum bilirubin. The study of glucuronic acid excretion could be eventually even more simple, but its increased elimination after short phenobarbital application in these experiments was found to be only negligible as has been observed by Zwacka and Frenzel (l9) , who found significant increase in glucuronic acid excretion in neonates only after 6 days of intramuscular treatment with phenobarbital.
In our experiments higher excretion of glucaric acid occurred before a significant increase of glucuronic acid elimination took Fig. 2 . Serum bilirubin decrease in percentage from the peak value on the 4th to the value on the 7th day plotted against urinary glucaric acid in micrograms per milligram of creatinine on the 7th day and the regression lines.
place. The observation relating to this subject was made by Kawada et al. (9) , who found increased L-ascorbic acid excretion after induction of rat liver microsomal glucuronolactonase by 5,5-diethylbarbituric acid and other drugs. Higher sensitivity to the inducing agents of glucaric rather than of glucuronic acid excretion, as observed in our experiments, is supported by Hanninen (2), who was able to assess a higher level of induction of the enzymes acting on glucuronic acid to glucaric acid transformation than of those responsible for glucuronic acid formation.
Lower response to orally administered phenobarbital could be explained by slower absorption rate and lower biologic availability of phenobarbital given orally in the presence of food (10) or in the form of coarse particles. The dependence of blood phenobarbital levels on particle size of intramuscularly injected drug was discussed by Miller and Fincher (13) . The minor influence of phenobarbital given orally in the form of crushed tablets on serum bilirubin levels was described in the previous paper (4).
SUMMARY
The urinary excretion of glucaric and glucuronic acid was investigated in neonates receiving phenobarbital intramuscularly or orally. Whereas there was no significant difference from the control-subjects in glucuronic acid elimination, the increase in glucaric acid excretion was significantly higher in the intramuscularly treated neonates. Infants with orally administered phenobarbital showed only insignificantly greater glucaric acid elimination. The decrease of serum bilirubin levels was more pronounced in the intramuscularly treated than in the orally treated group. The determination of glucaric acid may be an important reflection of hepatic microsomal induction of the enzymes of the glucuronic acid pathway.
